— Know what they know.
Not Investment Advice
Also trades as: AVCNF (OTC) · $vol 0M

AVCN.TO TSX

Avicanna Inc.
1W: -4.8% 1M: -16.7% 3M: -16.7% YTD: -44.4% 1Y: -63.6% 3Y: -71.4% 5Y: -90.7%
C$0.10 ($0.07)
+0.00 (+0.00%)
 
Weekly Expected Move ±13.4%
C$0 C$0 C$0 C$0 C$0
TSX · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 37 · C$12.6M mcap · 97M float · 0.163% daily turnover

Cash Flow Trends

Operating Cash Flow
-$3M -81.4% ▼
Capital Expenditures
$403K +27.8% ▲
5Y CAGR: -44.3%
Free Cash Flow
-$3M -50.4% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$29K +95.9% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income-$33M-$17M-$15M-$9M-$4M
Depreciation & Amort.$1M$894K$887K$777K$854K
Stock-Based Comp.$3M$1M$1M$2M$2M
Change in Working Capital$464K-$2M$1M$4M-$790K
Other Non-Cash Items$16M$5M$4M$262K-$565K
Operating Cash Flow-$14M-$12M-$7M-$1M-$3M
— Investing Activities —
Capital Expenditures-$1M-$789K-$67K-$45K-$403K
Acquisitions (Net)$0$300K$669K-$3M$0
Investment Purchases-$1M-$300K$0$0$0
Investment Sales$0$1M$180K$0$0
Other Investing-$1M$300K$28K-$495K$0
Investing Cash Flow-$3M$761K$810K-$3M-$403K
— Financing Activities —
Net Debt Issuance$671K$953K$65K-$553K-$2M
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$17M$17K$10M$2M$437K
Financing Cash Flow$17M$10M$10M$4M$3M
Net Change in Cash$825K-$1M$1M-$717K-$29K
Cash End of Period$1M$31K$1M$477K$448K
Free Cash Flow-$15M-$12M-$8M-$2M-$3M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms